{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:37:21Z","timestamp":1790786241604,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40257-025-00988-y","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:58:34Z","timestamp":1760723914000},"page":"121-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding Enthesitis in Psoriatic Disease: Insights and Implications"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1165-1173","authenticated-orcid":false,"given":"Rahaf Zyad","family":"Attar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel Zehra","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"5","key":"988_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","volume":"24","author":"E Christophers","year":"2010","unstructured":"Christophers E, Barker J, Griffiths C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548\u201354. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03463.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"988_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957\u201370. https:\/\/doi.org\/10.1056\/NEJMra1505557.","journal-title":"N Engl J Med"},{"issue":"4","key":"988_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1479-8077.2007.00303.x","volume":"10","author":"YY Leung","year":"2007","unstructured":"Leung YY, Lim KKT. Apsoriatic psoriatic arthritis. APLAR J Rheumatol. 2007;10(4):264\u20139. https:\/\/doi.org\/10.1111\/j.1479-8077.2007.00303.x.","journal-title":"APLAR J Rheumatol"},{"issue":"4","key":"988_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00000441-199810000-00008","volume":"316","author":"LR Espinoza","year":"1998","unstructured":"Espinoza LR, van Solingen R, Cuellar ML, Angulo J. Insights into the pathogenesis of psoriasis and psoriatic arthritis. Am J Med Sci. 1998;316(4):271\u20136. https:\/\/doi.org\/10.1097\/00000441-199810000-00008.","journal-title":"Am J Med Sci"},{"issue":"2","key":"988_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000341536","volume":"225","author":"DG McGonagle","year":"2012","unstructured":"McGonagle DG, Helliwell P, Veale D. Enthesitis in psoriatic disease. Dermatology. 2012;225(2):100\u20139. https:\/\/doi.org\/10.1159\/000341536.","journal-title":"Dermatology"},{"issue":"Suppl. 2","key":"988_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3899\/jrheum.2024-0593","volume":"51","author":"D McGonagle","year":"2024","unstructured":"McGonagle D, Abacar K, Kirkham B. Grappa 2023 debate: is psoriatic disease really a primary enthesitis that drives joint synovitis? The enthesitis hypothesis 25 years on. J Rheumatol. 2024;51(Suppl. 2):101\u20135. https:\/\/doi.org\/10.3899\/jrheum.2024-0593.","journal-title":"J Rheumatol"},{"issue":"6","key":"988_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/1756-185X.13835","volume":"23","author":"E BolkanG\u00fcnayd\u0131n","year":"2020","unstructured":"BolkanG\u00fcnayd\u0131n E, Alada\u011f P, Tecer D, Yenice IS, Ad\u0131\u015fen E, G\u00f6\u011f\u00fc\u015f FN. Ultrasonographic evaluation of subclinical enthesitis in patients with psoriasis. Int J Rheum Dis. 2020;23(6):744\u201352. https:\/\/doi.org\/10.1111\/1756-185X.13835.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"988_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.63032\/UNBM9076","volume":"3","author":"D SilteKaramanlioglu","year":"2024","unstructured":"SilteKaramanlioglu D, UnluOzkan F, CerenAr\u0131kan EE, Pirdal BZ, Ozturk G, Aktas I. Detection of subclinical enthesitis by ultrasonography in patients with psoriasis and controls. ARP Rheumatol. 2024;3(1):29\u201339. https:\/\/doi.org\/10.63032\/UNBM9076.","journal-title":"ARP Rheumatol."},{"issue":"1","key":"988_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbiomech.2004.10.025","volume":"39","author":"SLY Woo","year":"2006","unstructured":"Woo SLY, Abramowitch SD, Kilger R, Liang R. Biomechanics of knee ligaments: injury, healing, and repair. J Biomech. 2006;39(1):1\u201320. https:\/\/doi.org\/10.1016\/j.jbiomech.2004.10.025.","journal-title":"J Biomech"},{"key":"988_CR10","doi-asserted-by":"crossref","unstructured":"Lories RJ. Overview of joint and cartilage biology. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T, editors. Genetics of Bone Biology and Skeletal Disease. 2nd ed. London: Academic Press; 2018. p. 209\u2013225.","DOI":"10.1016\/B978-0-12-804182-6.00013-7"},{"issue":"1","key":"988_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101966","volume":"38","author":"R Sabido-Sauri","year":"2024","unstructured":"Sabido-Sauri R, Baraliakos X, Aydin SZ. Enthesopathies: mechanical, inflammatory or both? Best Pract Res Clin Rheumatol. 2024;38(1):101966. https:\/\/doi.org\/10.1016\/j.berh.2024.101966.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"988_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/diagnostics11040669","volume":"11","author":"S Mascarenhas","year":"2021","unstructured":"Mascarenhas S, Couette N. A systematic review of the inclusion of non-inflammatory ultrasonographic enthesopathy findings in enthesitis scoring indices. Diagnostics. 2021;11(4):669. https:\/\/doi.org\/10.3390\/diagnostics11040669.","journal-title":"Diagnostics"},{"issue":"12","key":"988_CR13","doi-asserted-by":"publisher","first-page":"BSR20193266","DOI":"10.1042\/BSR20193266","volume":"39","author":"YZ Ji","year":"2019","unstructured":"Ji YZ, Liu SR. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Biosci Rep. 2019;39(12):BSR20193266. https:\/\/doi.org\/10.1042\/BSR20193266.","journal-title":"Biosci Rep."},{"key":"988_CR14","first-page":"559","volume":"8","author":"H K\u00f6bner","year":"1976","unstructured":"K\u00f6bner H. Zur aetiologie der psoriasis. Vrtljscher f Dermat. 1976;8:559\u201361.","journal-title":"Vrtljscher f Dermat."},{"issue":"2","key":"988_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000104261","volume":"215","author":"A Kalayciyan","year":"2007","unstructured":"Kalayciyan A, Aydemir EH, Kotogyan A. Experimental Koebner phenomenon in patients with psoriasis. Dermatology. 2007;215(2):114\u20137.","journal-title":"Dermatology"},{"issue":"1","key":"988_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000545694","volume":"17","author":"Y Mima","year":"2025","unstructured":"Mima Y, Yamamoto M, Nishida N, Norimatsu Y, Iozumi K. Trauma-induced psoriatic arthritis: a deep K\u00f6bner phenomenon. Case Rep Dermatol. 2025;17(1):137. https:\/\/doi.org\/10.1159\/000545694.","journal-title":"Case Rep Dermatol"},{"issue":"2","key":"988_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/rheumatology\/key238","volume":"58","author":"F Arslan Alhussain","year":"2019","unstructured":"Arslan Alhussain F, Kasapoglu Gunal E, Kurum E, et al. Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound. Rheumatology. 2019;58(2):299\u2013303. https:\/\/doi.org\/10.1093\/rheumatology\/key238.","journal-title":"Rheumatology"},{"issue":"6","key":"988_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","volume":"14","author":"J Feld","year":"2018","unstructured":"Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363\u201371. https:\/\/doi.org\/10.1038\/s41584-018-0006-8.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"988_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/ard.57.3.135","volume":"57","author":"PS Helliwell","year":"1998","unstructured":"Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis. 1998;57(3):135\u201340. https:\/\/doi.org\/10.1136\/ard.57.3.135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"988_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semarthrit.2019.06.016","volume":"50","author":"D Solmaz","year":"2020","unstructured":"Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ. Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Semin Arthritis Rheum. 2020;50(1):42\u20137. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.016.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"988_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/annrheumdis-2017-212681","volume":"77","author":"I Tinazzi","year":"2018","unstructured":"Tinazzi I, McGonagle D, Aydin SZ, Chessa D, Marchetta A, Macchioni P. \u201cDeep Koebner\u201d phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis. Ann Rheum Dis. 2018;77(6):922\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212681.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"988_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett G, Lories RJ, D\u2019Agostino MA, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13(12):731\u201341. https:\/\/doi.org\/10.1038\/nrrheum.2017.188.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"988_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73(2):437\u201345. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203643.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"988_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","volume":"191","author":"SMJ Paulissen","year":"2013","unstructured":"Paulissen SMJ, van Hamburg JP, Davelaar N, Asmawidjaja PS, Hazes JMW, Lubberts E. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23. J Immunol. 2013;191(3):1364\u201372. https:\/\/doi.org\/10.4049\/jimmunol.1300274.","journal-title":"J Immunol"},{"issue":"7","key":"988_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-[gamma]t+ CD3+CD4-CD8-entheseal resident T cells. Nat Med. 2012;18(7):1069\u201378. https:\/\/doi.org\/10.1038\/nm.2817.","journal-title":"Nat Med"},{"issue":"7","key":"988_CR26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.2854","volume":"18","author":"RJ Lories","year":"2012","unstructured":"Lories RJ, McInnes IB. Primed for inflammation: enthesis-resident T cells. Nat Med. 2012;18(7):1018\u201320.","journal-title":"Nat Med"},{"issue":"2","key":"988_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","volume":"46","author":"AL Tan","year":"2007","unstructured":"Tan AL, Benjamin M, Toumi H, et al. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histological study. Rheumatol Oxf Engl. 2007;46(2):253\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/kel214.","journal-title":"Rheumatol Oxf Engl."},{"issue":"10","key":"988_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3899\/jrheum.171094","volume":"45","author":"PJ Mease","year":"2018","unstructured":"Mease PJ, Palmer JB, Liu M, et al. Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry. J Rheumatol. 2018;45(10):1389\u201396. https:\/\/doi.org\/10.3899\/jrheum.171094.","journal-title":"J Rheumatol"},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","volume":"23","author":"D McGonagle","year":"2009","unstructured":"McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol. 2009;23:9\u201313. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03363.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"988_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejr.2020.07.003","volume":"42","author":"R ElMallah","year":"2020","unstructured":"ElMallah R. Nail affection as a central part of the entheseal organ in psoriasis patients for early detection of psoriatic arthritis. Egypt Rheumatol. 2020;42(4):319\u201324. https:\/\/doi.org\/10.1016\/j.ejr.2020.07.003.","journal-title":"Egypt Rheumatol"},{"issue":"11","key":"988_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58111557","volume":"58","author":"M Agache","year":"2022","unstructured":"Agache M, Popescu CC, Popa L, Codreanu C. Ultrasound enthesitis in psoriasis patients with or without psoriatic arthritis, a cross-sectional analysis. Medicina (B Aires). 2022;58(11):1557. https:\/\/doi.org\/10.3390\/medicina58111557.","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"988_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/DAD.0000000000002328","volume":"45","author":"C Perrin","year":"2023","unstructured":"Perrin C. Are there signs of enthesitis in nail psoriasis? An immunohistological study of nail psoriasis with and without psoriatic arthritis. Am J Dermatopathol. 2023;45(1):40\u20136. https:\/\/doi.org\/10.1097\/DAD.0000000000002328.","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"988_CR33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/DAD.0000000000001947","volume":"43","author":"C Perrin","year":"2021","unstructured":"Perrin C. Focal synovial inflammation versus enthesitis theory in distal psoriatic arthritis: a pioneer histopathologic study. Am J Dermatopathol. 2021;43(12):898. https:\/\/doi.org\/10.1097\/DAD.0000000000001947.","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"988_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.1959.73000200002011a","volume":"169","author":"GL Cava","year":"1959","unstructured":"Cava GL. Enthesitis-traumatic disease of insertions. J Am Med Assoc. 1959;169(3):254\u20135. https:\/\/doi.org\/10.1001\/jama.1959.73000200002011a.","journal-title":"J Am Med Assoc"},{"key":"988_CR35","doi-asserted-by":"publisher","unstructured":"New tool for assessing enthesitis in patients with psoriatic arthritis. Nat Clin Pract Rheumatol. 2008;4(8):390. https:\/\/doi.org\/10.1038\/ncprheum0854.","DOI":"10.1038\/ncprheum0854"},{"issue":"2","key":"988_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"L Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis (extended report). Ann Rheum Dis. 2003;62(2):127\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"988_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/ard.2007.084244","volume":"68","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Mallon C, Morrow S, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index. Ann Rheum Dis. 2009;68(6):948\u201353. https:\/\/doi.org\/10.1136\/ard.2007.084244.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"988_CR38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Care Res. 2008;59(5):686\u201391. https:\/\/doi.org\/10.1002\/art.23568.","journal-title":"Arthritis Care Res"},{"issue":"S11","key":"988_CR39","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/acr.20577","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res. 2011;63(S11):S64-85. https:\/\/doi.org\/10.1002\/acr.20577.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"988_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03080-0","volume":"25","author":"REM Granados","year":"2023","unstructured":"Granados REM, Ladehesa-Pineda ML, Puche-Larrubia M\u00c1, et al. Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-perspa data. Arthritis Res Ther. 2023;25(1):99. https:\/\/doi.org\/10.1186\/s13075-023-03080-0.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"988_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s42358-019-0066-8","volume":"59","author":"PE Palominos","year":"2019","unstructured":"Palominos PE, de Campos APB, Ribeiro SLE, et al. Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a cross-sectional study comparing MASES, SPARCC and LEI. Adv Rheumatol. 2019;59(1):23. https:\/\/doi.org\/10.1186\/s42358-019-0066-8.","journal-title":"Adv Rheumatol"},{"issue":"1","key":"988_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/kex079","volume":"57","author":"A Marchesoni","year":"2018","unstructured":"Marchesoni A, De Marco G, Merashli M, et al. The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia. Rheumatology. 2018;57(1):32\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kex079.","journal-title":"Rheumatology"},{"key":"988_CR43","doi-asserted-by":"publisher","first-page":"1759720X2110038","DOI":"10.1177\/1759720X211003812","volume":"13","author":"M Sapsford","year":"2021","unstructured":"Sapsford M, Evans J, Clunie G, Jadon D. A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgia. Ther Adv Musculoskelet Dis. 2021;13:1759720X211003812. https:\/\/doi.org\/10.1177\/1759720X211003812.","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"3","key":"988_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10067-012-2111-4","volume":"32","author":"C Wiell","year":"2013","unstructured":"Wiell C, Szkudlarek M, Hasselquist M, et al. Power doppler ultrasonography of painful Achilles tendons and entheses in patients with and without spondyloarthropathy: a comparison with clinical examination and contrast-enhanced MRI. Clin Rheumatol. 2013;32(3):301\u20138. https:\/\/doi.org\/10.1007\/s10067-012-2111-4.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"988_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jbspin.2015.01.016","volume":"82","author":"E Acquacalda","year":"2015","unstructured":"Acquacalda E, Albert C, Montaudie H, et al. Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: a prospective study. Joint Bone Spine. 2015;82(4):267\u201371. https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.016.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"988_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4103\/idoj.IDOJ_446_18","volume":"11","author":"K Vyas","year":"2020","unstructured":"Vyas K, Jain SK, Mittal A, Kumar R, Saxena S, Malviya S. Sonographic evaluation of subclinical enthesopathy in patients of chronic plaque psoriasis. Indian Dermatol Online J. 2020;11(4):580\u20135. https:\/\/doi.org\/10.4103\/idoj.IDOJ_446_18.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"988_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.31138\/mjr.180923.ues","volume":"34","author":"S Boussaid","year":"2023","unstructured":"Boussaid S, Ben Aissa R, Rekik S, et al. Ultrasonography enthesitis and synovitis screening in psoriatic patients: a case control study. Mediterr J Rheumatol. 2023;34(4):495\u2013505. https:\/\/doi.org\/10.31138\/mjr.180923.ues.","journal-title":"Mediterr J Rheumatol"},{"issue":"3","key":"988_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/medsci12030040","volume":"12","author":"RC Dasc\u0103lu","year":"2024","unstructured":"Dasc\u0103lu RC, B\u0103rbulescu AL, Dinescu\u0218tefan C, Bi\u021b\u0103 CE, Stoica LE, et al. Subclinical enthesopathy in psoriasis: an ultrasonographic study. Med Sci. 2024;12(3):40. https:\/\/doi.org\/10.3390\/medsci12030040.","journal-title":"Med Sci"},{"issue":"5","key":"988_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.semarthrit.2010.05.009","volume":"40","author":"M Gutierrez","year":"2011","unstructured":"Gutierrez M, Filippucci E, De Angelis R, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40(5):407\u201312. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.009.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"988_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ard.2007.075101","volume":"67","author":"P Gisondi","year":"2008","unstructured":"Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis. 2008;67(1):26\u201330. https:\/\/doi.org\/10.1136\/ard.2007.075101.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"988_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/rheumatology\/ker078","volume":"50","author":"E Naredo","year":"2011","unstructured":"Naredo E, M\u00f6ller I, de Miguel E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology. 2011;50(10):1838\u201348. https:\/\/doi.org\/10.1093\/rheumatology\/ker078.","journal-title":"Rheumatology"},{"key":"988_CR52","unstructured":"Eder L, Acayaba de Toledo R, Bakewell C, Carron P, Elnady B, Haddad A, et al. The development and validation of a Diagnostic Ultrasound Enthesitis Score (DUET) for psoriatic arthritis [abstract]. Arthritis Rheumatol. 2025;77(Suppl 9). Available from: https:\/\/acrabstracts.org\/abstract\/the-development-and-validation-of-a-diagnostic-ultrasound-enthesitis-score-duet-for-psoriatic-arthritis\/. Accessed 2025 Oct 12."},{"issue":"7","key":"988_CR53","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3899\/jrheum.190512","volume":"47","author":"C Bakewell","year":"2020","unstructured":"Bakewell C, Aydin SZ, Ranganath VK, Eder L, Kaeley GS. Imaging techniques: options for the diagnosis and monitoring of treatment of enthesitis in psoriatic arthritis. J Rheumatol. 2020;47(7):973\u201382. https:\/\/doi.org\/10.3899\/jrheum.190512.","journal-title":"J Rheumatol"},{"issue":"10","key":"988_CR54","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3899\/jrheum.181095","volume":"46","author":"GA Bruyn","year":"2019","unstructured":"Bruyn GA, Iagnocco A, Naredo E, et al. OMERACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on. J Rheumatol. 2019;46(10):1388\u201393. https:\/\/doi.org\/10.3899\/jrheum.181095.","journal-title":"J Rheumatol"},{"key":"988_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3899\/jrheum.200128","volume":"96","author":"L Eder","year":"2020","unstructured":"Eder L, Kaeley GS, Aydin SZ. Development and validation of a sonographic enthesitis instrument in psoriatic arthritis: the GRAPPA diagnostic ultrasound enthesitis tool (DUET) project. J Rheumatol Suppl. 2020;96:50\u20132. https:\/\/doi.org\/10.3899\/jrheum.200128.","journal-title":"J Rheumatol Suppl"},{"key":"988_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmed.2020.00296","volume":"7","author":"AJ Mathew","year":"2020","unstructured":"Mathew AJ, \u00d8stergaard M. Magnetic resonance imaging of enthesitis in spondyloarthritis, including psoriatic arthritis: status and recent advances. Front Med. 2020;7:296. https:\/\/doi.org\/10.3389\/fmed.2020.00296.","journal-title":"Front Med"},{"issue":"8","key":"988_CR57","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/ijd.16645","volume":"62","author":"A Norden","year":"2023","unstructured":"Norden A, Oulee A, Ivanic M, Javadi SS, Han G, Wu JJ. The use of ultrasound to detect enthesitis as a potential guide for intervention in patients with psoriasis at risk of psoriatic arthritis: a systematic review. Int J Dermatol. 2023;62(8):973\u20139. https:\/\/doi.org\/10.1111\/ijd.16645.","journal-title":"Int J Dermatol"},{"issue":"6","key":"988_CR58","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1007\/s00330-023-09493-4","volume":"33","author":"ZT Chen","year":"2023","unstructured":"Chen ZT, Chen RF, Li XL, et al. The role of ultrasound in screening subclinical psoriatic arthritis in patients with moderate to severe psoriasis. Eur Radiol. 2023;33(6):3943\u201353. https:\/\/doi.org\/10.1007\/s00330-023-09493-4.","journal-title":"Eur Radiol"},{"issue":"4","key":"988_CR59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/annrheumdis-2011-200478","volume":"71","author":"ZR Ash","year":"2012","unstructured":"Ash ZR, Tinazzi I, Gallego CC, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis. 2012;71(4):553\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200478.","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"988_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216296","volume":"11","author":"YS Huang","year":"2022","unstructured":"Huang YS, Huang YH, Lin CH, Kuo CF, Huang YJ. Ultrasound can be usefully integrated with the clinical assessment of nail and enthesis involvement in psoriasis and psoriatic arthritis. J Clin Med. 2022;11(21):6296. https:\/\/doi.org\/10.3390\/jcm11216296.","journal-title":"J Clin Med"},{"issue":"8","key":"988_CR61","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3899\/jrheum.201471","volume":"48","author":"GS Kaeley","year":"2021","unstructured":"Kaeley GS, Eder L, Aydin SZ, Rich P, Bakewell CJ. Nail psoriasis: diagnosis, assessment, treatment options, and unmet clinical needs. J Rheumatol. 2021;48(8):1208\u201320. https:\/\/doi.org\/10.3899\/jrheum.201471.","journal-title":"J Rheumatol"},{"issue":"1","key":"988_CR62","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1038\/s41598-019-39985-7","volume":"9","author":"M Krajewska-W\u0142odarczyk","year":"2019","unstructured":"Krajewska-W\u0142odarczyk M, Owczarczyk-Saczonek A, Placek W, Wojtkiewicz M, Wiktorowicz A, Wojtkiewicz J. Distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis. Sci Rep. 2019;9(1):3628. https:\/\/doi.org\/10.1038\/s41598-019-39985-7.","journal-title":"Sci Rep"},{"issue":"Suppl._1","key":"988_CR63","doi-asserted-by":"publisher","first-page":"hcab116.010","DOI":"10.1093\/qjmed\/hcab116.010","volume":"114","author":"NM Sherif","year":"2021","unstructured":"Sherif NM, Ali Elwi M, El Mallah R, Ali Mohamed SS. Ultrasound in evaluation of subclinical enthesitis of extensor digitorum tendon and nail unit changes in psoriasis. QJM Int J Med. 2021;114(Suppl._1):hcab116.010. https:\/\/doi.org\/10.1093\/qjmed\/hcab116.010.","journal-title":"QJM Int J Med."},{"issue":"12","key":"988_CR64","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.3899\/jrheum.110505","volume":"38","author":"I Tinazzi","year":"2011","unstructured":"Tinazzi I, McGonagle D, Biasi D, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38(12):2691\u20132. https:\/\/doi.org\/10.3899\/jrheum.110505.","journal-title":"J Rheumatol"},{"issue":"6","key":"988_CR65","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10067-019-04445-0","volume":"38","author":"B Elnady","year":"2019","unstructured":"Elnady B, El Shaarawy NK, Dawoud NM, et al. Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years. Clin Rheumatol. 2019;38(6):1627\u201335. https:\/\/doi.org\/10.1007\/s10067-019-04445-0.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"988_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001067","volume":"5","author":"A Zabotti","year":"2019","unstructured":"Zabotti A, McGonagle DG, Giovannini I, et al. Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia. RMD Open. 2019;5(2):e001067. https:\/\/doi.org\/10.1136\/rmdopen-2019-001067.","journal-title":"RMD Open"},{"issue":"9","key":"988_CR67","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard-2023-224148","volume":"82","author":"A Zabotti","year":"2023","unstructured":"Zabotti A, Marco GD, Gossec L, et al. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Ann Rheum Dis. 2023;82(9):1162\u201370. https:\/\/doi.org\/10.1136\/ard-2023-224148.","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl. 1","key":"988_CR68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3899\/jrheum.211331","volume":"49","author":"LC Coates","year":"2022","unstructured":"Coates LC, Corp N, van der Windt DA, O\u2019Sullivan D, Soriano ER, Kavanaugh A. GRAPPA treatment recommendations: 2021 update. J Rheumatol. 2022;49(6 Suppl. 1):52\u20134. https:\/\/doi.org\/10.3899\/jrheum.211331.","journal-title":"J Rheumatol"},{"issue":"6","key":"988_CR69","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/ard-2024-225531","volume":"83","author":"L Gossec","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024;83(6):706\u201319. https:\/\/doi.org\/10.1136\/ard-2024-225531.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"988_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69(1):48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"988_CR71","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/art.40872","volume":"71","author":"JF Merola","year":"2019","unstructured":"Merola JF, Ogdie A. SEAM-PsA: seems like methotrexate works in psoriatic arthritis? Arthritis Rheumatol. 2019;71(7):1027\u20139. https:\/\/doi.org\/10.1002\/art.40872.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"988_CR72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.semarthrit.2018.05.011","volume":"48","author":"EG Araujo","year":"2019","unstructured":"Araujo EG, Englbrecht M, Hoepken S, et al. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Semin Arthritis Rheum. 2019;48(4):632\u20137. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.05.011.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"988_CR73","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045\u201350. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204858.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"988_CR74","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2011.150938","volume":"70","author":"DD Gladman","year":"2011","unstructured":"Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70(12):2152\u20134. https:\/\/doi.org\/10.1136\/ard.2011.150938.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"988_CR75","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3899\/jrheum.190540","volume":"47","author":"S Bakirci","year":"2020","unstructured":"Bakirci S, Solmaz D, Stephenson W, Eder L, Roth J, Aydin SZ. Entheseal changes in response to age, body mass index, and physical activity: an ultrasound study in healthy people. J Rheumatol. 2020;47(7):968\u201372. https:\/\/doi.org\/10.3899\/jrheum.190540.","journal-title":"J Rheumatol"},{"issue":"9","key":"988_CR76","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/rheumatology\/kew218","volume":"55","author":"Y Yumusakhuylu","year":"2016","unstructured":"Yumusakhuylu Y, Kasapoglu-Gunal E, Murat S, et al. A preliminary study showing that ultrasonography cannot differentiate between psoriatic arthritis and nodal osteoarthritis based on enthesopathy scores. Rheumatology. 2016;55(9):1703\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/kew218.","journal-title":"Rheumatology"},{"key":"988_CR77","unstructured":"Lihi E, Acayaba de Toledo R, Bakewell C, et al. The development and validation of a Diagnostic Ultrasound Enthesitis Score (DUET) for psoriatic arthritis. In: Arthritis & Rheumatology. Vol 77. Suppl 9. American College of Rheumatology; 2025:1959. Available from: https:\/\/acrabstracts.org\/abstract\/the-development-and-validation-of-a-diagnostic-ultrasound-enthesitis-score-duet-for-psoriatic-arthritis\/. Accessed 9 Oct 2025."},{"issue":"3","key":"988_CR78","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1080\/09546634.2021.1899112","volume":"33","author":"A Narcisi","year":"2022","unstructured":"Narcisi A, Valenti M, De Simone C, et al. Effects of TNF-\u03b1 inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients. J Dermatolog Treat. 2022;33(3):1703\u20136. https:\/\/doi.org\/10.1080\/09546634.2021.1899112.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"988_CR79","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/art.40778","volume":"71","author":"L Savage","year":"2019","unstructured":"Savage L, Goodfield M, Horton L, et al. Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study. Arthritis Rheumatol. 2019;71(4):626\u201331. https:\/\/doi.org\/10.1002\/art.40778.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"988_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063650","volume":"12","author":"RH Haberman","year":"2022","unstructured":"Haberman RH, MacFarlane KA, Catron S, et al. Efficacy of guselkumab, a selective IL-23 inhibitor, in preventing arthritis in a multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial. BMJ Open. 2022;12(12):e063650. https:\/\/doi.org\/10.1136\/bmjopen-2022-063650.","journal-title":"BMJ Open"},{"key":"988_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/PTT.S427775","volume":"14","author":"MI Fatani","year":"2024","unstructured":"Fatani MI, Al-homood I, Bedaiwi M, et al. Experiences of dermatologists and patients regarding psoriasis and its connection to psoriatic arthritis in Saudi Arabia. Psoriasis Targets Ther. 2024;14:11\u201322. https:\/\/doi.org\/10.2147\/PTT.S427775.","journal-title":"Psoriasis Targets Ther"},{"issue":"11","key":"988_CR82","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3899\/jrheum.2023-0424","volume":"50","author":"K Song","year":"2023","unstructured":"Song K, Webb L, Eder L, et al. Screening and referral strategies for the early recognition of psoriatic arthritis among patients with psoriasis: results of a GRAPPA survey. J Rheumatol. 2023;50(11):1439\u201345. https:\/\/doi.org\/10.3899\/jrheum.2023-0424.","journal-title":"J Rheumatol"},{"issue":"1","key":"988_CR83","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaad.2019.05.075","volume":"82","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM, Gottlieb AB, Cohen J, et al. Measuring psoriatic arthritis symptoms: a core domain in psoriasis clinical trials. J Am Acad Dermatol. 2020;82(1):54\u201361. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.075.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"988_CR84","doi-asserted-by":"publisher","first-page":"777","DOI":"10.36849\/JDD.9210","volume":"24","author":"S Romanelli","year":"2025","unstructured":"Romanelli S, Ball D, Hamade H, et al. Streamlining psoriatic arthritis screening and management using the IDEOM clinical framework: a quality improvement initiative. J Drugs Dermatol. 2025;24(8):777\u201381. https:\/\/doi.org\/10.36849\/JDD.9210.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"988_CR85","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/09546630902817887","volume":"20","author":"SL Taylor","year":"2009","unstructured":"Taylor SL, Petrie M, O\u2019Rourke KS, Feldman SR. Rheumatologists\u2019 recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients\u2019 joint symptoms. J Dermatol Treat. 2009;20(6):350\u20133. https:\/\/doi.org\/10.3109\/09546630902817887.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"988_CR86","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/jdv.14741","volume":"32","author":"P Gisondi","year":"2018","unstructured":"Gisondi P, Altomare G, Ayala F, et al. Consensus on the management of patients with psoriatic arthritis in a dermatology setting. J Eur Acad Dermatol Venereol. 2018;32(4):515\u201328. https:\/\/doi.org\/10.1111\/jdv.14741.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"988_CR87","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/bjd.18515","volume":"182","author":"D Solmaz","year":"2020","unstructured":"Solmaz D, Bakirci S, Al Onazi A, Al Osaimi N, Fahim S, Aydin SZ. Musculoskeletal ultrasound can improve referrals from dermatology to rheumatology for patients with psoriasis. Br J Dermatol. 2020;182(3):804\u20136. https:\/\/doi.org\/10.1111\/bjd.18515.","journal-title":"Br J Dermatol"},{"issue":"7","key":"988_CR88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11926-024-01146-9","volume":"26","author":"AL Ribeiro","year":"2024","unstructured":"Ribeiro AL, Eder L. From psoriasis to psoriatic arthritis: ultrasound insights connecting psoriasis with subclinical musculoskeletal inflammation and the path to psoriatic arthritis. Curr Rheumatol Rep. 2024;26(7):235\u201347. https:\/\/doi.org\/10.1007\/s11926-024-01146-9.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"988_CR89","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1093\/rheumatology\/kead592","volume":"63","author":"V Bartsch","year":"2024","unstructured":"Bartsch V, Fagni F, Krieter M, et al. Screening for psoriatic arthritis in dermatological settings\u2014are handheld ultrasound devices the gamechangers we hoped for? Rheumatology. 2024;63(11):e294\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/kead592.","journal-title":"Rheumatology"},{"issue":"1","key":"988_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis. Nat Rev Dis Primer. 2021;7(1):59. https:\/\/doi.org\/10.1038\/s41572-021-00293-y.","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"988_CR91","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","volume":"7","author":"A Kumthekar","year":"2020","unstructured":"Kumthekar A, Ogdie A. Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther. 2020;7(3):447. https:\/\/doi.org\/10.1007\/s40744-020-00215-6.","journal-title":"Rheumatol Ther"},{"issue":"4","key":"988_CR92","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","volume":"68","author":"L Eder","year":"2016","unstructured":"Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol. 2016;68(4):915\u201323. https:\/\/doi.org\/10.1002\/art.39494.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"988_CR93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233. https:\/\/doi.org\/10.1002\/art.24172.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"988_CR94","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s40744-021-00378-w","volume":"8","author":"A Zabotti","year":"2021","unstructured":"Zabotti A, De Lucia O, Sakellariou G, et al. Predictors, risk factors, and incidence rates of psoriatic arthritis development in psoriasis patients: a systematic literature review and meta-analysis. Rheumatol Ther. 2021;8(4):1519\u201334. https:\/\/doi.org\/10.1007\/s40744-021-00378-w.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"988_CR95","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1203475422112879.6","volume":"26","author":"J Chang","year":"2022","unstructured":"Chang J, Litvinov IV, Ly C, et al. Utilization of the Psoriasis Epidemiology Screening Tool (PEST): a risk stratification strategy for early referral of psoriatic arthritis patients to minimize irreversible erosive joint damage. J Cutan Med Surg. 2022;26(6):600\u20133. https:\/\/doi.org\/10.1177\/1203475422112879.6.","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"988_CR96","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00403-009-0981-3","volume":"301","author":"PL Dominguez","year":"2009","unstructured":"Dominguez PL, Husni ME, Holt EW, Tyler S, Qureshi AA. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res. 2009;301(8):573\u20139. https:\/\/doi.org\/10.1007\/s00403-009-0981-3.","journal-title":"Arch Dermatol Res"},{"key":"988_CR97","unstructured":"Walsh J. Accelerating psoriatic arthritis detection in patients with psoriasis: Direct-to-Patient Administration of Screening Questionnaires (D2P Screening). 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04110522. Accessed 10 Aug 2025."},{"key":"988_CR98","doi-asserted-by":"publisher","unstructured":"Sarabia S, Farrer C, Yeung J, Jerome D, Cook RJ, Eder L. Comparative efficacy of different triage methods for psoriatic arthritis: results from a prospective study in a rapid access clinic. Arthritis Care Res. 2022;74(8):1254-1262.  https:\/\/doi.org\/10.1002\/acr.24570.","DOI":"10.1002\/acr.24570"},{"issue":"10","key":"988_CR99","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1002\/art.21306","volume":"52","author":"PJ Mease","year":"2005","unstructured":"Mease PJ, Gladman DD, Ritchlin CT, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005;52(10):3279\u201389. https:\/\/doi.org\/10.1002\/art.21306.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"988_CR100","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/ard.2004.032268","volume":"64","author":"C Antoni","year":"2005","unstructured":"Antoni C, Krueger GG, de Vlam K, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. 2005;64(8):1150\u20137. https:\/\/doi.org\/10.1136\/ard.2004.032268.","journal-title":"Ann Rheum Dis"},{"key":"988_CR101","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c147","volume":"340","author":"W Sterry","year":"2010","unstructured":"Sterry W, Ortonne JP, Kirkham B, et al. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. BMJ. 2010;340:c147. https:\/\/doi.org\/10.1136\/bmj.c147.","journal-title":"BMJ"},{"key":"988_CR102","doi-asserted-by":"publisher","unstructured":"Kavanaugh A, van der Heijde D, McInnes IB, et al. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum. 2012;64(8):2504-2517. https:\/\/doi.org\/10.1002\/art.34436.","DOI":"10.1002\/art.34436"},{"issue":"11","key":"988_CR103","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/art.40226","volume":"69","author":"A Kavanaugh","year":"2017","unstructured":"Kavanaugh A, Husni ME, Harrison DD, et al. Safety and efficacy of intravenous golimumab in patients with active psoriatic arthritis. Arthritis Rheumatol. 2017;69(11):2151\u201361. https:\/\/doi.org\/10.1002\/art.40226.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"988_CR104","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","volume":"73","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Fleischmann R, Deodhar AA, et al. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis. 2014;73(1):48\u201355. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203696.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"988_CR105","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000582","volume":"4","author":"D Heijde","year":"2018","unstructured":"Heijde D, Deodhar A, FitzGerald O, et al. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. RMD Open. 2018;4(1):e000582. https:\/\/doi.org\/10.1136\/rmdopen-2017-000582.","journal-title":"RMD Open"},{"key":"988_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152259","volume":"63","author":"MA D\u2019Agostino","year":"2023","unstructured":"D\u2019Agostino MA, Carron P, Gaillez C, et al. Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension. Semin Arthritis Rheum. 2023;63:152259. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152259.","journal-title":"Semin Arthritis Rheum"},{"key":"988_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13075-018-1551-x","volume":"20","author":"P Nash","year":"2018","unstructured":"Nash P, Mease PJ, McInnes IB, et al. Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3). Arthritis Res Ther. 2018;20:47. https:\/\/doi.org\/10.1186\/s13075-018-1551-x.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"988_CR108","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/rheumatology\/keab784","volume":"61","author":"F Behrens","year":"2022","unstructured":"Behrens F, Sewerin P, de Miguel E, et al. Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial. Rheumatology. 2022;61(7):2856\u201366. https:\/\/doi.org\/10.1093\/rheumatology\/keab784.","journal-title":"Rheumatology"},{"issue":"1","key":"988_CR109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/annrheumdis-2019-215386","volume":"79","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Smolen JS, Behrens F, et al. A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-na\u00efve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Ann Rheum Dis. 2020;79(1):123\u201331. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215386.","journal-title":"Ann Rheum Dis"},{"issue":"10370","key":"988_CR110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(22)02302-9","volume":"401","author":"IB McInnes","year":"2023","unstructured":"McInnes IB, Asahina A, Coates LC, et al. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet. 2023;401(10370):25\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(22)02302-9.","journal-title":"Lancet"},{"issue":"10230","key":"988_CR111","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","volume":"395","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Rahman P, Gottlieb AB, et al. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2020;395(10230):1126\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(20)30263-4.","journal-title":"Lancet"},{"issue":"2","key":"988_CR112","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/annrheumdis-2021-221019","volume":"81","author":"LE Kristensen","year":"2022","unstructured":"Kristensen LE, Keiserman M, Papp K, et al. Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial. Ann Rheum Dis. 2022;81(2):225\u201331. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221019.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"988_CR113","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","volume":"384","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Anderson JK, Magrey M, et al. Trial of upadacitinib and adalimumab for psoriatic arthritis. N Engl J Med. 2021;384(13):1227\u201339. https:\/\/doi.org\/10.1056\/NEJMoa2022516.","journal-title":"N Engl J Med"},{"issue":"2","key":"988_CR114","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40744-018-0131-5","volume":"5","author":"P Nash","year":"2018","unstructured":"Nash P, Coates LC, Fleischmann R, et al. Efficacy of tofacitinib for the treatment of psoriatic arthritis: pooled analysis of two phase 3 studies. Rheumatol Ther. 2018;5(2):567\u201382. https:\/\/doi.org\/10.1007\/s40744-018-0131-5.","journal-title":"Rheumatol Ther."},{"issue":"6","key":"988_CR115","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/annrheumdis-2021-221664","volume":"81","author":"PJ Mease","year":"2022","unstructured":"Mease PJ, Deodhar AA, van der Heijde D, et al. Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Ann Rheum Dis. 2022;81(6):815\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221664.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"988_CR116","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease PJ, Gottlieb AB, van der Heijde D, et al. Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis. Ann Rheum Dis. 2017;76(9):1550\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210724.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"988_CR117","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000669","volume":"4","author":"DD Gladman","year":"2018","unstructured":"Gladman DD, Kavanaugh A, G\u00f3mez-Reino JJ, et al. Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1\u20133 studies. RMD Open. 2018;4(1):e000669. https:\/\/doi.org\/10.1136\/rmdopen-2018-000669.","journal-title":"RMD Open"},{"issue":"7","key":"988_CR118","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.40851","volume":"71","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Gladman DD, Collier DH, et al. Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheumatol. 2019;71(7):1112\u201324. https:\/\/doi.org\/10.1002\/art.40851.","journal-title":"Arthritis Rheumatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00988-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:50:59Z","timestamp":1769849459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00988-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00988-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alice B. Gottlieb is an Editorial Board member of the\n                      American Journal of Clinical Dermatology\n                      . She was not involved in the selection of peer reviewers for this article nor in any editorial decisions regarding its disposition. Rahaf Zyad Attar and Sibel Aydinhave no conflicts of interest that are directly relevant to the content of this article. Alice B. Gottlieb has received research\/educational grants from Bristol-Myers Squibb, Janssen, Moonlake, and UCB Pharma (all paid to Mount Sinai School of Medicine until 1 May, 2025). At UT Southwestern, she serves as a sub-investigator on studies sponsored by Janssen, Bristol-Myers Squibb, and UCB. She has also received honoraria as an advisory board member and consultant for Bristol-Myers Squibb, Eli Lilly, Janssen, Novartis, Oruka, Sanofi, SunPharma, Takeda, Teva, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"This study was based on previously published literature and did not involve the collection of new human or animal data; therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable. This article is based on previously published literature and does not include original data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"RA performed the initial conceptualization, conducted the literature review, and wrote the manuscript. SA and ABG had supervised the conceptualization and contributed to the review and editing of the manuscript. All authors approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}